Maryland is giving biotech firm Emergent BioSolutions a $2 million loan to double its footprint and staff in East Baltimore.
Emergent BioSolutions, which develops vaccines and other pharmaceuticals, will double its 58,000-square-foot manufacturing facility on Lombard Street to include more space for manufacturing, quality control cabs and warehouse space. Emergent expects to break ground on the expansion in the second quarter of 2015.